New personalized medicine publication Genome features Cancer Commons in its latest issue. The article highlights Cancer Commons’ mission, with supporting remarks from Founder Marty Tenenbaum, PhD, and Executive Director William Wong, PhD.
From the article:
“[Cancer Commons is] the very model of personalized medicine, a way for cancer patients to have their unique challenges analyzed against the largest data set possible and be shown the most relevant data to their individual case. This is important for patients who often feel like they are adrift once they’re diagnosed, Tenenbaum says.”